GLP-1 has been reported to suppress appetite, control energy intake, and enhance satiety through the gut–brain axis, which may reduce the risk of obesity-induced T2DM and play a key role in the pathogenesis of T2DM [182,183]. This evidence concerns the gene GCG and type 2 diabetes mellitus.